MedPath

In elderly patients over 90 years old with acute kidney injury post-infection, does prolonged intermittent renal replacement therapy improve outcomes compared to standard therapy?

Not Applicable
Completed
Conditions
Renal replacement therapy for acute kidney injury after infection in elderly patients
Urological and Genital Diseases
Registration Number
ISRCTN24896690
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
20
Inclusion Criteria

1. Patients over 90 years old
2. Acute kidney injury (AKI) due to infection
3. Received Prolonged Intermittent Renal Replacement Therapy (PIRRT)

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Measured using patient records:<br>1.Age at baseline<br>2.Gender at baseline<br>3.Systolic Blood Pressure: Average all measurements taken from baseline over the next 3 days<br>4.Diastolic Blood Pressure: Average all measurements taken from baseline over the next 3 days<br>5.Heart Rate: Average all measurements taken from baseline over the next 3 days<br>6.Creatinine at baseline<br>7.Estimated Glomerular Filtration Rate at baseline<br>8.Urea at baseline<br>9.Sodium at baseline<br>10.Potassium at baseline<br>11.Calcium at baseline<br>12.Phosphorus at baseline<br>13.B-type Natriuretic Peptide at baseline<br>14.Hemoglobin at baseline<br>15.White Blood Cell Count at baseline<br>16.Neutrophil Count at baseline<br>17.Lymphocyte Count at baseline<br>18.Platelet Count at baseline<br>19.C-Reactive Protein at baseline<br>20.Procalcitonin at baseline<br>21.Prothrombin Time at baseline<br>22.Activated Partial Thromboplastin Time at baseline<br>23.SOFA Score at baseline<br>24.APACHE II Score at baseline
Secondary Outcome Measures
NameTimeMethod
There are no secondary outcome measures
© Copyright 2025. All Rights Reserved by MedPath